Updated Jul 16, 2026
McGuire Daniel Patrick has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Daniel Patrick McGuire (often listed as Mcguire Daniel Patrick) is associated with Vanda Pharmaceuticals Inc. per SEC filings dated around 2026-06-08. The provided SEC context does not specify his official title or role within the company, and there are no additional public details in this context about his background, education, or career history. There is no indication of death within the scope of the most recent filing context; however, given name variations, there is a possibility of confusion with similarly named individuals. This biography is constrained to information available from the SEC filing context provided.
| Role | Insider |
|---|---|
| Notability | 25/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | VNDA | Vanda Pharmaceuticals Inc. | A — Grant or award | 80.0K | $0.00 |
Daniel Patrick McGuire (often listed as Mcguire Daniel Patrick) is associated with Vanda Pharmaceuticals Inc. per SEC filings dated around 2026-06-08. The provided SEC context does not specify his official title or role within the company, and there are no additional public details in this context about his background, education, or career history. There is no indication of dea…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McGuire Daniel Patrick profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.